Pyxis Oncology Stock Market Value
| PYXS Stock | USD 2.01 0.18 9.84% |
| Symbol | Pyxis |
Pyxis Oncology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pyxis Oncology. If investors know Pyxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pyxis Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 0.298 | Return On Assets (0.21) | Return On Equity (0.39) |
The market value of Pyxis Oncology is measured differently than its book value, which is the value of Pyxis that is recorded on the company's balance sheet. Investors also form their own opinion of Pyxis Oncology's value that differs from its market value or its book value, called intrinsic value, which is Pyxis Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pyxis Oncology's market value can be influenced by many factors that don't directly affect Pyxis Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pyxis Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pyxis Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pyxis Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pyxis Oncology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pyxis Oncology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pyxis Oncology.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Pyxis Oncology on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Pyxis Oncology or generate 0.0% return on investment in Pyxis Oncology over 180 days. Pyxis Oncology is related to or competes with Zura Bio, Altamira Therapeutics, Elevation Oncology, Mereo BioPharma, PDS Biotechnology, X4 Pharmaceuticals, and Corvus Pharmaceuticals. Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat ca... More
Pyxis Oncology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pyxis Oncology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pyxis Oncology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 61.13 | |||
| Value At Risk | (8.17) | |||
| Potential Upside | 7.24 |
Pyxis Oncology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pyxis Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pyxis Oncology's standard deviation. In reality, there are many statistical measures that can use Pyxis Oncology historical prices to predict the future Pyxis Oncology's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (1.79) | |||
| Treynor Ratio | (3.93) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pyxis Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pyxis Oncology Backtested Returns
Pyxis Oncology maintains Sharpe Ratio (i.e., Efficiency) of -0.0718, which implies the firm had a -0.0718% return per unit of risk over the last 3 months. Pyxis Oncology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pyxis Oncology's Coefficient Of Variation of (1,241), risk adjusted performance of (0.05), and Variance of 51.63 to confirm the risk estimate we provide. The company holds a Beta of 0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pyxis Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pyxis Oncology is expected to be smaller as well. At this point, Pyxis Oncology has a negative expected return of -0.52%. Please make sure to check Pyxis Oncology's potential upside and day median price , to decide if Pyxis Oncology performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Pyxis Oncology has very weak reverse predictability. Overlapping area represents the amount of predictability between Pyxis Oncology time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pyxis Oncology price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Pyxis Oncology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Pyxis Oncology lagged returns against current returns
Autocorrelation, which is Pyxis Oncology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pyxis Oncology's stock expected returns. We can calculate the autocorrelation of Pyxis Oncology returns to help us make a trade decision. For example, suppose you find that Pyxis Oncology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pyxis Oncology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pyxis Oncology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pyxis Oncology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pyxis Oncology stock over time.
Current vs Lagged Prices |
| Timeline |
Pyxis Oncology Lagged Returns
When evaluating Pyxis Oncology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pyxis Oncology stock have on its future price. Pyxis Oncology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pyxis Oncology autocorrelation shows the relationship between Pyxis Oncology stock current value and its past values and can show if there is a momentum factor associated with investing in Pyxis Oncology.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pyxis Stock Analysis
When running Pyxis Oncology's price analysis, check to measure Pyxis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pyxis Oncology is operating at the current time. Most of Pyxis Oncology's value examination focuses on studying past and present price action to predict the probability of Pyxis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pyxis Oncology's price. Additionally, you may evaluate how the addition of Pyxis Oncology to your portfolios can decrease your overall portfolio volatility.